Cigar Rights of America

Oliva Serie V 5 x 54 Box Pressed

There’s likely not much left to be written about Oliva’s Serie V line; having debuted in June 2007, the line has become a staple in…

Padrón Black No. 100

Padrón is not known for making new cigars. It’s not to say the company doesn’t, as it typically adds about at least one new cigar…

Cigar Rights of America’s 2021 Freedom Sampler Shipping

The 2021 edition of Cigar Rights of America’s annual cigar sampler has begun shipping to CRA member stores, and as in past years, it features…

CRA Names New Leadership

Cigar Rights of America has announced a variety of new leadership roles. Gary Pesh—owner of Old Virginia Tobacco Co., a retailer—has been elected as chairman…

Ten Questions for 2021

There are less than a dozen hours of the year—the year—remaining. As I’ve done at this point of each year for over a decade, it’s…

Cigar Rights of America Freedom Sampler 2020 Heads to Retailers

The 2020 version of the Cigar Rights of America Freedom Sampler is on its way to retailers, and the distribution will be much more widespread…

CRA Freedom Sampler 2020 Coming This Winter

There will be a new Cigar Rights of America Freedom Sampler on store shelves before the holiday season, and it will once again feature cigars…

Court Vacates FDA’s Cigar Warning Label Requirement

The U.S. District Court of the District of Columbia has vacated FDA’s warning label requirements for cigars and pipe tobacco. If that sounds familiar, it’s…

Cigar Industry, FDA Due Back in D.C. Court Tomorrow

The cigar industry and the U.S. Food & Drug Administration will meet in virtual federal court tomorrow afternoon to discuss FDA’s plans to defer premium…

Cigar Industry, FDA Meet in Court Ahead of September Substantial Equivalence Deadline

Attorneys for the cigar industry and the U.S. Food & Drug Administration (FDA) were back in federal court to present arguments about whether part or…

Six Thoughts: Appeals Court Strikes Down All FDA Cigar & Pipe Warning Labels

Earlier today, the U.S. Court of Appeals for the District of Columbia Circuit ruled that the U.S. Food & Drug Administration (FDA) could not require…